Literature DB >> 20814129

Proteinuria in adult Saudi patients with sickle cell disease is not associated with identifiable risk factors.

Aamer Aleem1.   

Abstract

Renal involvement in patients with sickle cell disease (SCD) is associated with significant morbidity and mortality. Proteinuria is common in patients with SCD and is a risk factor for future development of renal failure. We sought to identify risk factors, if any, associated with proteinuria in adult Saudi patients with SCD. We studied 67 patients with SCD followed-up at the King Khalid University Hospital, Riyadh, Saudi Arabia. All patients underwent 24-hour urine collection to measure creatinine clearance and to quantify proteinuria. In addition, blood was examined for evaluation of hematological and biochemical parameters. Clinical information was gathered from review of the patients' charts. A urine protein level of more than 0.150 grams/24 hours was considered abnormal. Urine protein was correlated with various clinical and laboratory parameters. Thirty-one males and 36 females were evaluated. The mean age of the cohort was 23.8 (± 7.2) years. Twenty-seven patients (40.3%) had proteinuria of more than 0.150 grams/24 hours. The study group had a mean hemoglobin level of 8.5 (± 2.8) g/dL and mean fetal hemoglobin (HbF) level of 14.4% (± 7.3%). Majority of the patients (61) had hemoglobin SS genotype and six patients had S-ß⁰ thalassemia. None of the parameters evaluated correlated with proteinuria although there was a borderline association with older age and higher systolic blood pressure (P = 0.073 and 0.061 respectively). Hydroxyurea use for more than a year was not beneficial. In conclusion, our study suggests that proteinuria in adult Saudi patients is not associated with any clear identifiable risk factors.

Entities:  

Mesh:

Year:  2010        PMID: 20814129

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  6 in total

1.  Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.

Authors:  Ashley Thrower; Emily J Ciccone; Poulami Maitra; Vimal K Derebail; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2018-11-21       Impact factor: 6.998

Review 2.  The nephropathy of sickle cell trait and sickle cell disease.

Authors:  Kenneth I Ataga; Santosh L Saraf; Vimal K Derebail
Journal:  Nat Rev Nephrol       Date:  2022-02-21       Impact factor: 42.439

3.  Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent.

Authors:  Geraldo B Silva Junior; Ana Patrícia F Vieira; Amanda X Couto Bem; Marília P Alves; Gdayllon C Meneses; Alice M C Martins; Sonia M H A Araújo; Alexandre V Libório; Elizabeth F Daher
Journal:  Int J Clin Pharm       Date:  2014-06-17

4.  Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease.

Authors:  Rajaa Marouf; Adekunle D Adekile; Hadeel El-Muzaini; Rasha Abdulla; Olusegun A Mojiminiyi
Journal:  Ann Hematol       Date:  2021-04-02       Impact factor: 3.673

Review 5.  The glomerulopathy of sickle cell disease.

Authors:  Kenneth I Ataga; Vimal K Derebail; David R Archer
Journal:  Am J Hematol       Date:  2014-06-19       Impact factor: 10.047

6.  Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis.

Authors:  Kenneth I Ataga; Victor R Gordeuk; Irene Agodoa; Jennifer A Colby; Kimberly Gittings; Isabel E Allen
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.